tiprankstipranks
Trending News
More News >
Catalyst Pharmaceutical Partners (DE:CN2)
:CN2
Advertisement

Catalyst Pharma (CN2) Similar Stocks

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Catalyst Pharma
€17.98
€2.27B
11.56
-16.06%
4 Buy
0 Hold
0 Sell
Strong Buy
Amicus
$8.87
$2.74B
-19.22%
7 Buy
1 Hold
0 Sell
Strong Buy
Travere Therapeutics
$32.34
$2.98B
83.13%
12 Buy
2 Hold
0 Sell
Strong Buy
Ocular Therapeutix
$10.85
$2.26B
0.65%
11 Buy
0 Hold
0 Sell
Strong Buy
ImmunityBio
$2.13
$2.10B
-59.81%
2 Buy
0 Hold
0 Sell
Moderate Buy
Liquidia Technologies
$26.09
$2.27B
-18.24
140.90%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:CN2
Catalyst Pharma
17.98
-4.08
-18.50%
FOLD
Amicus
8.87
-1.82
-17.03%
TVTX
Travere Therapeutics
32.34
13.31
69.94%
OCUL
Ocular Therapeutix
10.85
-0.11
-1.00%
IBRX
ImmunityBio
2.13
-3.32
-60.92%
LQDA
Liquidia Technologies
26.09
15.36
143.15%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis